Screening and the costs of treating colorectal cancer.

Abstract:

:The objective of this paper is to compare the hospital costs of treating patients with colorectal cancers detected as a result of a faecal occult blood screening programme with those of patients whose cancers present symptomatically (control group). Patient-specific cost estimates are made, using case records and hospital accounts, for 360 patients over 3 years. Mean treatment costs for the group offered screening and for the control group are calculated to be 3,179 pounds and 2,966 pounds respectively, although the difference between these means is insignificant. Low treatment costs in the case of screen-detected cancers are largely accounted for by polypectomy with no subsequent readmission; in the control group case, they tend to be accounted for by early patient death. For the sample as a whole, the costs of treating very early-, and very late-, stage cancer are significantly lower than those of treating cancers in the intermediate stages. On the basis of trial evidence, the introduction of mass screening for colorectal cancer is unlikely to give rise to substantial economies in the costs of treatment.

journal_name

Br J Cancer

authors

Whynes DK,Walker AR,Chamberlain JO,Hardcastle JD

doi

10.1038/bjc.1993.462

subject

Has Abstract

pub_date

1993-11-01 00:00:00

pages

965-8

issue

5

eissn

0007-0920

issn

1532-1827

journal_volume

68

pub_type

杂志文章
  • Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules.

    abstract:BACKGROUND:Enzastaurin, an oral serine-threonine kinase inhibitor, was initially developed as an ATP-competitive selective inhibitor against protein kinase Cβ. However, the mechanism by which enzastaurin contributes to tumourigenesis remains unclear. METHODS:We analysed the anti-tumour effects of enzastaurin in 22 lun...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.7

    authors: Shimokawa T,Seike M,Soeno C,Uesaka H,Miyanaga A,Mizutani H,Kitamura K,Minegishi Y,Noro R,Okano T,Yoshimura A,Gemma A

    更新日期:2012-02-28 00:00:00

  • Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.

    abstract:BACKGROUND:This multicentre, open-label study evaluated the efficacy and safety of SPI-1620, an analogue of endothelin-1, administered in combination with docetaxel as second-line treatment for patients with advanced biliary tract cancer (ABTC). METHODS:Eligible patients received continuous cycles of combination thera...

    journal_title:British journal of cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1038/bjc.2017.160

    authors: Kim R,Chiorean EG,Amin M,Rocha-Lima CMS,Gandhi J,Harris WP,Song T,Portnoy D

    更新日期:2017-07-11 00:00:00

  • Avoidable deaths and random variation in patients' survival.

    abstract:BACKGROUND:Random error in the numbers of avoidable deaths among cancer patients has not been considered in earlier studies. METHODS:Methods to obtain valid confidence intervals (CIs) for numbers of avoidable deaths were developed. The excess mortality rates were estimated for patients diagnosed with colon cancer in f...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.169

    authors: Seppä K,Hakulinen T,Läärä E

    更新日期:2012-05-22 00:00:00

  • Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice.

    abstract::The growth and spread of tumour cells depends on adequate vasculature. We have previously reported that the expression of interleukin-8 (IL-8) directly correlates with the vascularity of human gastric carcinomas. To provide evidence for a causal role of IL-8 in angiogenesis and tumorigenicity of human gastric cancer, ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6690742

    authors: Kitadai Y,Takahashi Y,Haruma K,Naka K,Sumii K,Yokozaki H,Yasui W,Mukaida N,Ohmoto Y,Kajiyama G,Fidler IJ,Tahara E

    更新日期:1999-10-01 00:00:00

  • Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.

    abstract:BACKGROUND:Melatonin induces apoptosis in many different cancer cell lines, including hepatocellular carcinoma cells. However, the responsible pathways have not been clearly elucidated. A member of the forkhead transcription factors' family, FoxO3a, has been implicated in the expression of the proapoptotic protein Bim ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.563

    authors: Carbajo-Pescador S,Steinmetz C,Kashyap A,Lorenz S,Mauriz JL,Heise M,Galle PR,González-Gallego J,Strand S

    更新日期:2013-02-05 00:00:00

  • Tumour and cellular localization by use of monoclonal and polyclonal antibodies to placental alkaline phosphatase.

    abstract::Monoclonal and polyclonal antibodies against placental alkaline phosphatase (PLAP) were evaluated for tumour immunolocalization of human PLAP-producing Hep 2 tumours in nude mice. The antibodies were labelled with 125I and injected i.p. in mice with developing Hep 2 tumours. The distribution of 125I-anti PLAP in vario...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1984.23

    authors: Jeppsson A,Wahren B,Millán JL,Stigbrand T

    更新日期:1984-02-01 00:00:00

  • Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.

    abstract::In vivo models of acquired resistance to the platinum-based agents cisplatin (CDDP), carboplatin (CBDCA), iproplatin (CHIP) and tetraplatin have been established using a panel of six parent human ovarian carcinoma lines, two (HX/110 and PXN/87) being derived from previously untreated patients. Resistance has been gene...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1993.5

    authors: Jones M,Siracky J,Kelland LR,Harrap KR

    更新日期:1993-01-01 00:00:00

  • Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.

    abstract::Studies of families who segregate BRCA2 mutations have found that men who carry disease-associated mutations have an increased risk of prostate cancer, particularly early-onset disease. A study of sporadic prostate cancer in the UK reported a prevalence of 2.3% for protein-truncating BRCA2 mutations among patients dia...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6603929

    authors: Agalliu I,Karlins E,Kwon EM,Iwasaki LM,Diamond A,Ostrander EA,Stanford JL

    更新日期:2007-09-17 00:00:00

  • Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE).

    abstract:BACKGROUND:Factors related to early stimulation of the immune system (breastfeeding, proxies for exposure to infectious agents, normal delivery, and exposure to animals in early life) have been suggested to decrease the risk of childhood acute lymphoblastic leukaemia (ALL). METHODS:The national registry-based case-con...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2015.53

    authors: Ajrouche R,Rudant J,Orsi L,Petit A,Baruchel A,Lambilliotte A,Gambart M,Michel G,Bertrand Y,Ducassou S,Gandemer V,Paillard C,Saumet L,Blin N,Hémon D,Clavel J

    更新日期:2015-03-17 00:00:00

  • Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2.

    abstract::Endosialin is a transmembrane glycoprotein selectively expressed in blood vessels and stromal fibroblasts of various human tumours. It has been functionally implicated in angiogenesis, but the factors that control its expression have remained unclear. As insufficient delivery of oxygen is a driving force of angiogenes...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604685

    authors: Ohradanova A,Gradin K,Barathova M,Zatovicova M,Holotnakova T,Kopacek J,Parkkila S,Poellinger L,Pastorekova S,Pastorek J

    更新日期:2008-10-21 00:00:00

  • Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database.

    abstract:BACKGROUND:Recent studies suggest that older patients in the United Kingdom are not benefiting as much from improvements in cancer treatments as their younger counterparts. We investigate whether this might be partly due to differential referral rates using ovarian cancer as an example. METHODS:From the General Practi...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605593

    authors: Tate AR,Nicholson A,Cassell JA

    更新日期:2010-03-16 00:00:00

  • Penetration of capecitabine and its metabolites into malignant and healthy tissues of patients with advanced breast cancer.

    abstract::Capecitabine is an oral prodrug of 5-fluorouracil (FU). Since FU concentrations achieved in malignant lesions are an important determinant of efficacy, we investigated the intratumoral transcapillary transfer of capecitabine and its metabolites in vivo. A total of 10 patients with skin metastases from breast cancer re...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600809

    authors: Mader RM,Schrolnberger C,Rizovski B,Brunner M,Wenzel C,Locker G,Eichler HG,Mueller M,Steger GG

    更新日期:2003-03-10 00:00:00

  • Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.

    abstract:BACKGROUND:Several recent studies have demonstrated that microRNAs (miRNAs) are stably detectable in the plasma/serum. We hypothesised that miR-18a in the plasma is a potential biomarker in patients with pancreatic cancer. METHODS:miR-18a is located in the miR-17-92 cluster and reported to be highly expressed in pancr...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.453

    authors: Morimura R,Komatsu S,Ichikawa D,Takeshita H,Tsujiura M,Nagata H,Konishi H,Shiozaki A,Ikoma H,Okamoto K,Ochiai T,Taniguchi H,Otsuji E

    更新日期:2011-11-22 00:00:00

  • Possible associations between ELF electromagnetic fields, DNA damage response processes and childhood leukaemia.

    abstract::Epidemiology has shown an association between exposure to extremely low frequency (ELF) electromagnetic fields (EMF) and childhood leukaemia. The causal nature and biological basis of this association are however questionable. Studies with aneuploid cell lines raised the hypothesis that ELF EMF may act as a coleukaemo...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6601010

    authors: Hone P,Edwards A,Halls J,Cox R,Lloyd D

    更新日期:2003-06-16 00:00:00

  • Control of cell proliferation in human glioma by glucocorticoids.

    abstract::Survival and proliferation of cell cultures from human anaplastic astrocytomas were shown to be enhanced by glucocorticoids with an optimal concentration of approximately 2.5 x 10(-5)M (10 micrograms/ml). The stimulation of proliferation was only observed in a clonal growth assay and was reversed as the size of indivi...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1980.161

    authors: Freshney RI,Sherry A,Hassanzadah M,Freshney M,Crilly P,Morgan D

    更新日期:1980-06-01 00:00:00

  • Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening.

    abstract::We determined the prevalence of type-specific hrHPV infections in the Netherlands on cervical scrapes of 45 362 women aged 18-65 years. The overall hrHPV prevalence peaked at the age of 22 with peak prevalence of 24%. Each of the 14 hrHPV types decreased significantly with age (P-values between 0.0009 and 0.03). The p...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604162

    authors: Coupé VM,Berkhof J,Bulkmans NW,Snijders PJ,Meijer CJ

    更新日期:2008-02-12 00:00:00

  • Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

    abstract::The tumour suppressor gene p53 has been found to be mutated or inactivated at high frequency in several common human tumours. We have examined a series of exocrine pancreatic carcinomas for over-expression of mutant forms of p53 by immunohistochemistry with a panel of specific antibodies. We found immunodetectable p53...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1991.467

    authors: Barton CM,Staddon SL,Hughes CM,Hall PA,O'Sullivan C,Klöppel G,Theis B,Russell RC,Neoptolemos J,Williamson RC

    更新日期:1991-12-01 00:00:00

  • Effect of hormone depletion on cell survival in the EMR-86 rat mammary carcinoma.

    abstract::Growth of the transplantable EMR-86 rat mammary carcinoma depends on elevated prolactin levels which are induced by oestrogenic stimulation of the pituitary. We investigated histological and cell kinetic changes during tumour regression after removal of implanted oestrogen pellets (EP), and we especially focused on th...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1996.232

    authors: Wijsman JH,Cornelisse CJ,Keijzer R,van de Velde CJ,Elvers B,van Dierendonck JH

    更新日期:1996-05-01 00:00:00

  • HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells.

    abstract::HuR, a ubiquitously expressed member of the Hu protein family that binds and stabilizes an AU-rich element (ARE)-containing mRNAs, is known to shuttle between the nucleus and the cytoplasm via several export pathways. When normal cells were treated with heat shock, HuR was exported to the cytoplasm in a chromosome mai...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605084

    authors: Hasegawa H,Kakuguchi W,Kuroshima T,Kitamura T,Tanaka S,Kitagawa Y,Totsuka Y,Shindoh M,Higashino F

    更新日期:2009-06-16 00:00:00

  • Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage.

    abstract::Abnormalities of the p53 tumor-suppressor gene are found in a significant proportion of astrocytic brain tumours. We studied tumour specimens from 74 patients evaluated over 20 years at the Massachusetts General Hospital, where clinical outcome could be determined and sufficient pathologic material was available for i...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6602161

    authors: Pardo FS,Hsu DW,Zeheb R,Efird JT,Okunieff PG,Malkin DM

    更新日期:2004-11-01 00:00:00

  • A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.

    abstract::Darbepoetin alfa is a novel erythropoiesis stimulating protein (NESP), which stimulates erythropoiesis by the same mechanism as recombinant human erythropoietin (rHuEPO). NESP has been shown to be safe and efficacious in patients with chronic renal failure. NESP is biochemically distinct from rHuEPO, due to its increa...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1054/bjoc.2001.1748

    authors: Glaspy J,Jadeja JS,Justice G,Kessler J,Richards D,Schwartzberg L,Rigas J,Kuter D,Harmon D,Prow D,Demetri G,Gordon D,Arseneau J,Saven A,Hynes H,Boccia R,O'Byrne J,Colowick AB

    更新日期:2001-04-01 00:00:00

  • Targeting gene transcription: a new strategy to down-regulate c-erbB-2 expression in mammary carcinoma.

    abstract::Overexpression of the c-erbB-2 proto-oncogene in mammary carcinoma is frequently associated with amplification of the c-erbB-2 gene, but it also occurs from single-copy gene. Studies in mammary-derived cell lines have shown that, whether or not the gene is amplified, there is a 6- to 8-fold increase in the accumulatio...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1995.146

    authors: Hollywood DP,Hurst HC

    更新日期:1995-04-01 00:00:00

  • Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.

    abstract:BACKGROUND:Human papillomavirus (HPV) testing in oropharyngeal squamous cell carcinoma (OPSCC) is now advocated. Demonstration of transcriptionally active high-risk HPV (HR-HPV) in fresh tumour tissue is considered to be the analytical 'gold standard'. Clinical testing has focused on formalin-fixed paraffin-embedded (F...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2013.63

    authors: Schache AG,Liloglou T,Risk JM,Jones TM,Ma XJ,Wang H,Bui S,Luo Y,Sloan P,Shaw RJ,Robinson M

    更新日期:2013-04-02 00:00:00

  • Aetiology of bone cancer, and some other cancers, in the young.

    abstract::The well-known peak of bone cancer during the second decade was found to be closely associated with changes in growth velocity at the adolescent growth spurt, for males and females in England and Wales. Distinct accumulations in the second and third decades could be recognized for cancers of ovary, testis, prostate an...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1970.24

    authors: Hems G

    更新日期:1970-06-01 00:00:00

  • A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC).

    abstract::For the first time in a clinical study oral Ifosfamide was used: 65 elderly or unfit patients with small cell lung cancer (SCLC) were treated as outpatients with fractionated oral Ifosfamide and Etoposide. Forty patients (62%) had extensive stage (ED) disease. The median age of the patients was 66 years. In the 60 pat...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1989.265

    authors: Cerny T,Lind M,Thatcher N,Swindell R,Stout R

    更新日期:1989-08-01 00:00:00

  • Somatic-cell hybrids producing antibodies against CEA.

    abstract::Monoclonal antibodies to carcinoembryonic antigen (CEA) promise improved specificity for the measurement of this widely expressed human cancer antigen. A mouse monoclonal antibody binds weakly to CEA in perchloric acid extracts of tumour but strongly to CEA similarly isolated from serum, and its spectrum of cancer det...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1981.1

    authors: Rogers GT,Rawlins GA,Bagshawe KD

    更新日期:1981-01-01 00:00:00

  • Prostaglandin-like material extracted from squamous carcinomas of the head and neck.

    abstract::Tumour-associated prostaglandin-like material, assessed by bioassay, has been examined in 37 patients with primary and metastatic squamous carcinomas of the head and neck, previously treated by radiotherapy and chemotherapy followed by radical surgery. High amounts of prostaglandin-like material were extracted from tu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1980.31

    authors: Bennett A,Carter RL,Stamford IF,Tanner NS

    更新日期:1980-02-01 00:00:00

  • The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.

    abstract::Antibody-dependent cellular cytotoxicity (ADCC) is considered to be the major mechanism through which tumour cells, upon treatment with anti-tumour MAbs, are eliminated in vivo. However, the relative importance of various parameters that influence the efficacy of ADCC is unclear. Here we present in vitro data on the i...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1998.518

    authors: Velders MP,van Rhijn CM,Oskam E,Fleuren GJ,Warnaar SO,Litvinov SV

    更新日期:1998-08-01 00:00:00

  • Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.

    abstract:BACKGROUND:Recent studies have indicated the prognostic value of tumour subtype and pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). However these results were reported after a short follow-up and using a standard Cox model which could be unsatisfactory for time-dependent factors. In the prese...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2015.174

    authors: Baulies S,Belin L,Mallon P,Senechal C,Pierga JY,Cottu P,Sablin MP,Sastre X,Asselain B,Rouzier R,Reyal F

    更新日期:2015-06-30 00:00:00

  • Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.

    abstract:BACKGROUND:We used bleomycin, etoposide, cisplatin (BEP), the most effective regimen in the treatment of germ cell tumours (GCTs) and increased dose-density by using pegfilgrastim to shorten cycle length. Our aim was to assess safety and tolerability. METHODS:Sixteen male patients with intermediate or poor prognosis m...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.309

    authors: Rimmer Y,Chester J,Joffe J,Stark D,Shamash J,Powles T,White J,Wason J,Parashar D,Armstrong G,Mazhar D,Williams MV

    更新日期:2011-09-06 00:00:00